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Background/introduction
To assess safety and effectiveness of non-invasive high
intensity 3T MR guided Focused Ultrasound Surgery
(MRgFUS) treatment of localized prostate cancer as sal-
vage therapy and as an alternative to active surveillance.
Methods
14 patients with biopsy proven focal T2 prostate cancer
(low-to-intermediate risk: PSA max 12 and Gleason max
3+4), confirmed on a previous multiparametric MR
exam (Discovery 750, GE) including dynamic contrast
enhanced (DCE) imaging (Gd-BOPTA, Bracco), under-
went MRgFUS ablation (ExAblate, InSightec). 1 patient
had already performed radiotherapy without clinical
success, 1 patient underwent US-guided Focused Ultra-
sound treatment with residual tumour tissue inside the
gland needing a second treatment; the last 2 enrolled
patients were part of an active surveillance regimen. All
patients refused radical laparoscopic prostatectomy.
MRgFUS treatment was carried out on the MR identifi-
able lesion (max 2) using a patient specific energy
(3000-8500 J) and real time MR thermometry monitor
for correct treatment location. Non-perfused volume
(NPV) in the post-ablative MRI was used for necrosis
assessment.
Results and conclusions
Results: No significant complications were observed in
all subjects during or immediately after the procedure.
Post-treatment MRI demonstrated extensive coagulative
necrosis at the site of sonication. At follow-up examina-
tions 3 patients were free of residual viable tumor within
the treated area; in the remaining patient, 10% of resi-
dual tumor was observed within the NPV. There was a
variable amount of isolated cancer tissue (Gleason
max 7, 3+4) within the non-treated parenchyma that
was neither identifiable at MRI nor at biopsy.
Conclusion: Our results suggest that MR guided
Focused Ultrasound Surgery is a safe and effective mod-
ality to determine >90% necrosis of identifiable prostate
cancer; other prospective studies are needed to extend
success rate in larger cohort.
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